Associate Professor, Medicine, Oregon Health and Science University School of Medicine
Oncology
Dr. Joshi J. Alumkal, MD
|
|
Give Review
Doctor Joshi J. Alumkal, MD works in the field of Oncology. He studied medicine at University of Texas Southwestern Medical School. He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Joshi J. Alumkal, MD is a published doctor. He has 23 papers published. The most current publication "Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by 18F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Surviva..." Dr. Joshi J. Alumkal accepts Medicare.
Publications
- Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by 18F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Surviva...
- Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Can...
- Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate Cancer.
- Orteronel for the treatment of prostate Cancer.
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate Cancer: results from an open-label, multicenter phase I/II study.
- Immunohistochemical Expression of ERG in the Molecular Epidemiology of Fatal Prostate Cancer Study.
- Targeted MET Inhibition in Castration-Resistant Prostate Cancer: A Randomized Phase 2 Study and Biomarker Analysis With Rilotumumab Plus Mitoxantrone and Prednisone.
- A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell Carcinoma.
- C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate Cancer (CRPC): Confirmatory results.
- Through the looking glass.
- Effect of DNA methylation on identification of aggressive prostate Cancer.
- Early use of chemotherapy in conjunction with radical Prostatectomy.
- Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation.
- hADA2a and hADA3: new players in beta-catenin signaling.
- Sulforaphane destabilizes the androgen receptor in prostate Cancer cells by inactivating histone deacetylase 6.
- Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of Cancer subtypes.
- Epigenetic regulation of androgen receptor signaling in prostate Cancer.
- A phase II study of paclitaxel poliglumex in combination with transdermal estradiol for the treatment of metastatic castration-resistant prostate Cancer after docetaxe...
- Emerging therapies in castrate-resistant prostate Cancer.
- Antitumour activity of MDV3100 in castration-resistant prostate Cancer: a phase 1-2 study.
- Surgery-associated factor VIII inhibitors in patients without hemophilia.
- A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate Cancer.
Schools
Baylor College Of Medicine
Sidney Kimmel Comp Cancer Center At Johns Hopkins
Conditions Treated
- Acute Leukemia
- AdRenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
University of Texas Southwestern Medical School -
Baylor College of Medicine
Drug Facts
| NPI NUMBER | 1114036720 | |
| NPPES Provider LastName | ALUMKAL | |
| NPPES Provider FirstName | JOSHI | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 151.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114036720 |
| Last Name Of The Provider | ALUMKAL |
| First Name Of The Provider | JOSHI |
| View All |
Similar Doctors
|
|
Dr. Ken K. Lee, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kathryn R. Shell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie N. Graff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina Vaccaro, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alison K. Conlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tarunpreet Bains, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rom S. Leidner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jacqueline Vuky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles D. Blanke, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Nagendra R. Tirumali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Galen, MD |
|
|
Dr. Brandon M. Hayes-Lattin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Mary E. Gramling, PT |